跳至主要内容
临床试验/NCT03496272
NCT03496272Unknown不适用

Atrial Fibrillation (AF) Cycle Length Measured on Transesophageal Echocardiography : a Feasible Parameter for Predicting the Recurrence of AF in Patients With AF Converted to Sinus Rhythm After DC Cardioversion

Pusan National University Yangsan Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
AF free survival rate at 6 months after DCCV

研究概览

简要总结

Background: The atrial fibrillation cycle length (AFCL) measured by electrophysiologic study is well known parameter for the maintenance of sinus rhythm after DC cardioversion (DCCV) or ablation therapy. The aim of this study was to test whether a AFCL measured by transesophageal echocardiography (AFCLTEE) could predict the outcome after DCCV.

Methods: In 100 consecutive patients with non-valvular AF, TEE will be performed within 6 hours before DCCV. The AFCLTEE was measured by averaging 10 sequential peak to peak intervals of atrial fibrillary waves seen in the pulsed wave Doppler image on the left atrial appendage. The primary endpoint was AF free survival rate at 6 months after DCCV.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • atrial fibrillation

排除标准

  • moderate or severe mitral stenosis
  • prosthetic heart valve

结局指标

主要结局

AF free survival rate at 6 months after DCCV

时间窗: 6 month

Atrial fibrillation free state at 6 months after direct current cardioversion

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yong Hyun Park

Associate Professor

Pusan National University Yangsan Hospital

研究点 (1)

Loading locations...

相似试验

Atrial Fibrillation Cycle Length Measured on... | 临床试验